Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods Read more about Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods
Developing Computable Phenotypes for Medical Product Safety Surveillance: Innovative Methods and Data Sources Read more about Developing Computable Phenotypes for Medical Product Safety Surveillance: Innovative Methods and Data Sources
Characterization of Mothers in the Sentinel Distributed Database Mother-Infant Linkage Table Read more about Characterization of Mothers in the Sentinel Distributed Database Mother-Infant Linkage Table
Characterization of Confounding Covariate Data Capture in the U.S. Food and Drug Administration’s Sentinel Distributed Database Read more about Characterization of Confounding Covariate Data Capture in the U.S. Food and Drug Administration’s Sentinel Distributed Database
Cannabis-Related Healthcare Encounters Among Commercially Insured Adults Aged 18-64 years Contributing Data to the US Food and Drug Administration’s Sentinel, 2017-2022 Read more about Cannabis-Related Healthcare Encounters Among Commercially Insured Adults Aged 18-64 years Contributing Data to the US Food and Drug Administration’s Sentinel, 2017-2022
Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies Read more about Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies
Assessment of Utilization Patterns of New Molecular Entities Approved in 2022 using the Sentinel Distributed Database Read more about Assessment of Utilization Patterns of New Molecular Entities Approved in 2022 using the Sentinel Distributed Database
Addressing the Threat of Confounding in Pharmacoepidemiology with Innovative Methods: Lessons from the FDA Sentinel Innovation Center Read more about Addressing the Threat of Confounding in Pharmacoepidemiology with Innovative Methods: Lessons from the FDA Sentinel Innovation Center
Incidence of Hospitalized Tachyarrhythmia in Patients with Type 2 Diabetes Mellitus Using Tirzepatide or Other Long-Acting Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: A Descriptive Analysis Read more about Incidence of Hospitalized Tachyarrhythmia in Patients with Type 2 Diabetes Mellitus Using Tirzepatide or Other Long-Acting Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: A Descriptive Analysis